SEEK (Drug Discovery) Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
4
- Investments
-
1
SEEK (Drug Discovery) General Information
Description
Developer of pharmaceutical drugs intended to bring safe, effective and low-cost treatments to patients. The company specializes in research, development and sell over-the-counter and prescription medicines through modifying existing medicines to improve their efficacy, using existing medicines in new indications and creating new chemical entities as well as operates a number of clinics, enabling clients to improve human health in major disease areas and get cured.
Contact Information
Website
www.seekacure.comCorporate Office
- London BioScience Innovation Centre
- 2 Royal College Street
- London NW1 0NH
- England, United Kingdom
Corporate Office
- London BioScience Innovation Centre
- 2 Royal College Street
- London NW1 0NH
- England, United Kingdom
SEEK (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SEEK (Drug Discovery) Patents
SEEK (Drug Discovery) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2017248680-A1 | Chagas antigens and antibodies and compositions, methods and uses thereof | Inactive | 14-Apr-2016 | ||
| CA-3020856-A1 | Chagas antigens and antibodies and compositions, methods and uses thereof | Pending | 14-Apr-2016 | ||
| EP-3442569-A1 | Chagas antigens and antibodies and compositions, methods and uses thereof | Pending | 14-Apr-2016 | ||
| US-10973897-B2 | Chagas antigens and antibodies and compositions, methods and uses thereof | Active | 14-Apr-2016 | ||
| US-20170296637-A1 | Chagas antigens and antibodies and compositions, methods and uses thereof | Active | 14-Apr-2016 | A61K39/005 |
SEEK (Drug Discovery) Signals
SEEK (Drug Discovery) Acquisitions (1)
SEEK (Drug Discovery)’s most recent deal was a Merger/Acquisition with ValiSeek. The deal was made on 08-Apr-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ValiSeek | 08-Apr-2014 | Merger/Acquisition | Drug Discovery |
SEEK (Drug Discovery) Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Conservbio | London, United Kingdom | 2020 | |
| TRx Biosciences | London, United Kingdom | 2019 | |
| Tangent Reprofiling | London, United Kingdom | 2008 |
SEEK (Drug Discovery) FAQs
-
When was SEEK (Drug Discovery) founded?
SEEK (Drug Discovery) was founded in 2004.
-
Where is SEEK (Drug Discovery) headquartered?
SEEK (Drug Discovery) is headquartered in London, United Kingdom.
-
What is the size of SEEK (Drug Discovery)?
SEEK (Drug Discovery) has 8 total employees.
-
What industry is SEEK (Drug Discovery) in?
SEEK (Drug Discovery)’s primary industry is Drug Discovery.
-
Is SEEK (Drug Discovery) a private or public company?
SEEK (Drug Discovery) is a Private company.
-
What is SEEK (Drug Discovery)’s current revenue?
The current revenue for SEEK (Drug Discovery) is .
-
How much funding has SEEK (Drug Discovery) raised over time?
SEEK (Drug Discovery) has raised $4.24M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process